HC Wainwright Reiterates Buy Rating for Transcat (NASDAQ:TRNS)

HC Wainwright reiterated their buy rating on shares of Transcat (NASDAQ:TRNS) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $156.00 price target on the scientific and technical instruments company’s stock. HC Wainwright also issued estimates for Transcat’s Q4 2025 earnings at $0.48 EPS.

Separately, Craig Hallum decreased their price target on shares of Transcat from $150.00 to $138.00 and set a “buy” rating for the company in a report on Wednesday, July 31st. One analyst has rated the stock with a sell rating, two have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, Transcat currently has an average rating of “Hold” and an average target price of $127.25.

Transcat Trading Down 3.5 %

Shares of TRNS stock opened at $95.57 on Tuesday. Transcat has a 12-month low of $84.45 and a 12-month high of $147.12. The business’s fifty day simple moving average is $122.34 and its 200-day simple moving average is $121.99. The company has a market cap of $874.47 million, a PE ratio of 48.27 and a beta of 0.67.

Transcat (NASDAQ:TRNS) last released its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.62%. The business had revenue of $67.83 million during the quarter, compared to analysts’ expectations of $70.30 million. During the same quarter last year, the business posted $0.41 earnings per share. The company’s quarterly revenue was up 8.0% compared to the same quarter last year. On average, equities analysts forecast that Transcat will post 2.06 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Conestoga Capital Advisors LLC boosted its position in Transcat by 17.9% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after purchasing an additional 137,830 shares in the last quarter. Hood River Capital Management LLC lifted its stake in shares of Transcat by 21.6% in the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock valued at $23,558,000 after purchasing an additional 34,947 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Transcat by 28.8% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after buying an additional 17,743 shares in the last quarter. Raymond James & Associates grew its position in Transcat by 157.2% during the third quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock valued at $2,494,000 after buying an additional 12,622 shares during the period. Finally, Janus Henderson Group PLC increased its holdings in Transcat by 208.3% in the first quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock valued at $1,147,000 after buying an additional 6,957 shares in the last quarter. 98.34% of the stock is currently owned by institutional investors and hedge funds.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.